A new podcast from industry experts MarketScan explains why social determinants of health are critical to patient care.

Dizal has received FDA approval for Zegfrovy to treat adults with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

The UK Government is pushing for a single, unified digital patient record within the NHS, but experts have shared cybersecurity concerns.